These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10197490)
21. Is there an indication for prophylactic endoscopic paravariceal injection sclerotherapy in patients with liver cirrhosis and portal hypertension? Paquet KJ; Koussouris P Endoscopy; 1986 May; 18 Suppl 2():32-5. PubMed ID: 3519193 [TBL] [Abstract][Full Text] [Related]
22. Prospective controlled trial of elective endoscopic sclerotherapy in comparison with percutaneous transhepatic obliteration of esophageal varices in patients with nonalcoholic cirrhosis. Terabayashi H; Ohnishi K; Tsunoda T; Nakata H; Saito M; Tanaka H; Iida S; Nomura F; Okuda K Gastroenterology; 1987 Dec; 93(6):1205-9. PubMed ID: 3315824 [TBL] [Abstract][Full Text] [Related]
23. Trial of sclerosing agents in patients with oesophageal varices. Kitano S; Iso Y; Yamaga H; Hashizume M; Higashi H; Sugimachi K Br J Surg; 1988 Aug; 75(8):751-3. PubMed ID: 3048533 [TBL] [Abstract][Full Text] [Related]
24. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. Akahoshi T; Hashizume M; Tomikawa M; Kawanaka H; Yamaguchi S; Konishi K; Kinjo N; Maehara Y J Gastroenterol Hepatol; 2008 Nov; 23(11):1702-9. PubMed ID: 18713295 [TBL] [Abstract][Full Text] [Related]
25. Merits of prophylactic sclerotherapy for esophageal varices concomitant unresectable hepatocellular carcinoma: prospective randomized study. Akahoshi T; Tomikawa M; Tsutsumi N; Hashizume M; Maehara Y Dig Endosc; 2014 Mar; 26(2):172-7. PubMed ID: 23650913 [TBL] [Abstract][Full Text] [Related]
26. Prophylactic sclerotherapy in cirrhotics--preliminary results of a prospective, controlled, randomized trial. Gupta P; Kar P; Chakrovarty A Indian J Gastroenterol; 1993 Jan; 12(1):27. PubMed ID: 8330921 [No Abstract] [Full Text] [Related]
27. Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate. Kitano S; Koyanagi N; Iso Y; Higashi H; Sugimachi K Hepatology; 1987; 7(5):810-5. PubMed ID: 3498673 [TBL] [Abstract][Full Text] [Related]
28. Prophylactic sclerotherapy of large esophageal varices. Santangelo WC; Dueno MI; Estes BL; Krejs GJ N Engl J Med; 1988 Mar; 318(13):814-8. PubMed ID: 3281001 [TBL] [Abstract][Full Text] [Related]
29. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices. Thakeb F; Salama Z; Salama H; Abdel Raouf T; Abdel Kader S; Abdel Hamid H Endoscopy; 1995 Jun; 27(5):358-64. PubMed ID: 7588349 [TBL] [Abstract][Full Text] [Related]
30. Endoscopic sclerotherapy of oesophageal varices. A clinical study. Söderlund C Acta Chir Scand Suppl; 1985; 524():1-86. PubMed ID: 3893006 [TBL] [Abstract][Full Text] [Related]
31. [Endoscopic sclerotherapy of esophageal varices in pediatric patients]. Salvatierra A; Granella L; Guevara ML; Barrios M; García MI; Salvatierra L G E N; 1992; 46(1):1-3. PubMed ID: 1305111 [TBL] [Abstract][Full Text] [Related]
32. Endoscopic injection sclerotherapy for esophageal varices using a transparent hood. Horigome H; Nomura T; Nakao H; Kanematsu T; Joh T; Ohara H; Itoh M Am J Gastroenterol; 2000 Dec; 95(12):3679-80. PubMed ID: 11151939 [No Abstract] [Full Text] [Related]
33. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial. Henderson JM; Kutner MH; Millikan WJ; Galambos JT; Riepe SP; Brooks WS; Bryan FC; Warren WD Ann Intern Med; 1990 Feb; 112(4):262-9. PubMed ID: 2404448 [TBL] [Abstract][Full Text] [Related]
34. Endoscopic variceal ligation is a sufficient procedure for the treatment of oesophageal varices in patients with hepatitis C liver cirrhosis: comparison with injection sclerotherapy. Hata Y; Hamada E; Takahashi M; Ota S; Ogura K; Shiina S; Okamoto M; Okudaira T; Teratani T; Maeda S; Koike Y; Sato S; Obi S; Tanaka T; Kawabe T; Shiratori Y; Kawase T; Nomura M; Omata M J Gastroenterol Hepatol; 1999 Mar; 14(3):236-40. PubMed ID: 10197492 [TBL] [Abstract][Full Text] [Related]
35. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. Cello JP; Grendell JH; Crass RA; Weber TE; Trunkey DD N Engl J Med; 1987 Jan; 316(1):11-5. PubMed ID: 3491317 [TBL] [Abstract][Full Text] [Related]
36. Prophylactic sclerotherapy in nonalcoholic liver cirrhosis: preliminary results of a prospective controlled randomized trial. Russo A; Giannone G; Magnano A; Passanisi G; Longo C World J Surg; 1989; 13(2):149-53. PubMed ID: 2658361 [TBL] [Abstract][Full Text] [Related]
37. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices. Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669 [TBL] [Abstract][Full Text] [Related]
38. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial. Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917 [TBL] [Abstract][Full Text] [Related]